Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Mesalamine market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Mesalaminemarket, defines the market attractiveness level of Mesalamine market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Mesalamine industry, describes the types of Mesalamine market, the applications of major players and the market size, and deeply analyzes the current situation of the global Mesalamine market and the development prospects and opportunities of Mesalamine industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Mesalamine market in Chapter 13.
By Player:
Salix Pharmaceuticals
Cipla
Cosmo Pharmaceuticals
Lunan Better Pharmaceutical
Chiesi Farmaceutici
Pfizer
Teva
AstraZeneca
Takeda
Tillotts Pharma
Sandoz Mesalamine
Abbvie
Nogra Pharma
Dr Falk Pharma
Shanghai Sine Promod Pharmaceutical
Mylan
Synmosa Biopharma Corporation
Ferring
Allergan
Janssen (Johnson & Johnson)
Boehringer Ingelheim
By Type:
Capsule
Tablets
By End-User:
Adult
Children
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Mesalamine Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Mesalamine Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Mesalamine Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Mesalamine Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Mesalamine Market Analysis and Outlook to 2022
-
7.1 Global Mesalamine Consumption (2017-2022)
-
7.2 United States Mesalamine Consumption (2017-2022)
-
7.3 Europe Mesalamine Consumption (2017-2022)
-
7.4 China Mesalamine Consumption (2017-2022)
-
7.5 Japan Mesalamine Consumption (2017-2022)
-
7.6 India Mesalamine Consumption (2017-2022)
-
7.7 South Korea Mesalamine Consumption (2017-2022)
8 Region and Country-wise Mesalamine Market Analysis and Outlook to 2028
-
8.1 Global Mesalamine Consumption Forecast (2022-2028)
-
8.2 United States Mesalamine Consumption Forecast (2022-2028)
-
8.3 Europe Mesalamine Consumption Forecast (2022-2028)
-
8.4 China Mesalamine Consumption Forecast (2022-2028)
-
8.5 Japan Mesalamine Consumption Forecast (2022-2028)
-
8.6 India Mesalamine Consumption Forecast (2022-2028)
-
8.7 South Korea Mesalamine Consumption Forecast (2022-2028)
9 Global Mesalamine Market Outlook by Types and Applications to 2022
-
9.1 Global Mesalamine Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Capsule Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Tablets Consumption and Growth Rate (2017-2022)
-
9.2 Global Mesalamine Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Adult Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Children Consumption and Growth Rate (2017-2022)
10 Global Mesalamine Market Outlook by Types and Applications to 2028
-
10.1 Global Mesalamine Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Capsule Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Tablets Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Mesalamine Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Adult Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Children Consumption Forecast and Growth Rate (2022-2028)
11 Global Mesalamine Import and Export Analysis (Top 5 Countries)
-
11.1 Global Mesalamine Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Mesalamine Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Mesalamine Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Mesalamine Market Competitive Analysis
-
14.1 Salix Pharmaceuticals
-
14.1.1 Salix Pharmaceuticals Company Details
-
14.1.2 Salix Pharmaceuticals Mesalamine Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Salix Pharmaceuticals Mesalamine Product and Service
-
14.2 Cipla
-
14.2.1 Cipla Company Details
-
14.2.2 Cipla Mesalamine Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Cipla Mesalamine Product and Service
-
14.3 Cosmo Pharmaceuticals
-
14.3.1 Cosmo Pharmaceuticals Company Details
-
14.3.2 Cosmo Pharmaceuticals Mesalamine Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Cosmo Pharmaceuticals Mesalamine Product and Service
-
14.4 Lunan Better Pharmaceutical
-
14.4.1 Lunan Better Pharmaceutical Company Details
-
14.4.2 Lunan Better Pharmaceutical Mesalamine Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Lunan Better Pharmaceutical Mesalamine Product and Service
-
14.5 Chiesi Farmaceutici
-
14.5.1 Chiesi Farmaceutici Company Details
-
14.5.2 Chiesi Farmaceutici Mesalamine Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Chiesi Farmaceutici Mesalamine Product and Service
-
14.6 Pfizer
-
14.6.1 Pfizer Company Details
-
14.6.2 Pfizer Mesalamine Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Pfizer Mesalamine Product and Service
-
14.7 Teva
-
14.7.1 Teva Company Details
-
14.7.2 Teva Mesalamine Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Teva Mesalamine Product and Service
-
14.8 AstraZeneca
-
14.8.1 AstraZeneca Company Details
-
14.8.2 AstraZeneca Mesalamine Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 AstraZeneca Mesalamine Product and Service
-
14.9 Takeda
-
14.9.1 Takeda Company Details
-
14.9.2 Takeda Mesalamine Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Takeda Mesalamine Product and Service
-
14.10 Tillotts Pharma
-
14.10.1 Tillotts Pharma Company Details
-
14.10.2 Tillotts Pharma Mesalamine Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Tillotts Pharma Mesalamine Product and Service
-
14.11 Sandoz Mesalamine
-
14.11.1 Sandoz Mesalamine Company Details
-
14.11.2 Sandoz Mesalamine Mesalamine Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Sandoz Mesalamine Mesalamine Product and Service
-
14.12 Abbvie
-
14.12.1 Abbvie Company Details
-
14.12.2 Abbvie Mesalamine Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 Abbvie Mesalamine Product and Service
-
14.13 Nogra Pharma
-
14.13.1 Nogra Pharma Company Details
-
14.13.2 Nogra Pharma Mesalamine Sales, Price, Value and Gross Profit (2017-2022)
-
14.13.3 Nogra Pharma Mesalamine Product and Service
-
14.14 Dr Falk Pharma
-
14.14.1 Dr Falk Pharma Company Details
-
14.14.2 Dr Falk Pharma Mesalamine Sales, Price, Value and Gross Profit (2017-2022)
-
14.14.3 Dr Falk Pharma Mesalamine Product and Service
-
14.15 Shanghai Sine Promod Pharmaceutical
-
14.15.1 Shanghai Sine Promod Pharmaceutical Company Details
-
14.15.2 Shanghai Sine Promod Pharmaceutical Mesalamine Sales, Price, Value and Gross Profit (2017-2022)
-
14.15.3 Shanghai Sine Promod Pharmaceutical Mesalamine Product and Service
-
14.16 Mylan
-
14.16.1 Mylan Company Details
-
14.16.2 Mylan Mesalamine Sales, Price, Value and Gross Profit (2017-2022)
-
14.16.3 Mylan Mesalamine Product and Service
-
14.17 Synmosa Biopharma Corporation
-
14.17.1 Synmosa Biopharma Corporation Company Details
-
14.17.2 Synmosa Biopharma Corporation Mesalamine Sales, Price, Value and Gross Profit (2017-2022)
-
14.17.3 Synmosa Biopharma Corporation Mesalamine Product and Service
-
14.18 Ferring
-
14.18.1 Ferring Company Details
-
14.18.2 Ferring Mesalamine Sales, Price, Value and Gross Profit (2017-2022)
-
14.18.3 Ferring Mesalamine Product and Service
-
14.19 Allergan
-
14.19.1 Allergan Company Details
-
14.19.2 Allergan Mesalamine Sales, Price, Value and Gross Profit (2017-2022)
-
14.19.3 Allergan Mesalamine Product and Service
-
14.20 Janssen (Johnson & Johnson)
-
14.20.1 Janssen (Johnson & Johnson) Company Details
-
14.20.2 Janssen (Johnson & Johnson) Mesalamine Sales, Price, Value and Gross Profit (2017-2022)
-
14.20.3 Janssen (Johnson & Johnson) Mesalamine Product and Service
-
14.21 Boehringer Ingelheim
-
14.21.1 Boehringer Ingelheim Company Details
-
14.21.2 Boehringer Ingelheim Mesalamine Sales, Price, Value and Gross Profit (2017-2022)
-
14.21.3 Boehringer Ingelheim Mesalamine Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Mesalamine
-
Figure Mesalamine Picture
-
Table Global Mesalamine Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Mesalamine Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Mesalamine Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Mesalamine Consumption by Country (2017-2022)
-
Figure United States Mesalamine Consumption and Growth Rate (2017-2022)
-
Table Europe Mesalamine Consumption and Growth Rate (2017-2022)
-
Figure China Mesalamine Consumption and Growth Rate (2017-2022)
-
Figure Japan Mesalamine Consumption and Growth Rate (2017-2022)
-
Figure India Mesalamine Consumption and Growth Rate (2017-2022)
-
Figure South Korea Mesalamine Consumption and Growth Rate (2017-2022)
-
Figure Global Mesalamine Consumption Forecast by Country (2022-2028)
-
Figure United States Mesalamine Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Mesalamine Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Mesalamine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Mesalamine Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Mesalamine Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Mesalamine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Capsule Consumption and Growth Rate (2017-2022)
-
Figure Global Tablets Consumption and Growth Rate (2017-2022)
-
Figure Global Adult Consumption and Growth Rate (2017-2022)
-
Figure Global Children Consumption and Growth Rate (2017-2022)
-
Figure Global Capsule Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Tablets Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Adult Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Children Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Mesalamine Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Mesalamine Export by Region (Top 5 Countries) (2017-2028)
-
Table Salix Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Salix Pharmaceuticals Mesalamine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Salix Pharmaceuticals Mesalamine Product and Service
-
Table Cipla (Foundation Year, Company Profile and etc.)
-
Table Cipla Mesalamine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Cipla Mesalamine Product and Service
-
Table Cosmo Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Cosmo Pharmaceuticals Mesalamine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Cosmo Pharmaceuticals Mesalamine Product and Service
-
Table Lunan Better Pharmaceutical (Foundation Year, Company Profile and etc.)
-
Table Lunan Better Pharmaceutical Mesalamine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Lunan Better Pharmaceutical Mesalamine Product and Service
-
Table Chiesi Farmaceutici (Foundation Year, Company Profile and etc.)
-
Table Chiesi Farmaceutici Mesalamine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Chiesi Farmaceutici Mesalamine Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Mesalamine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Mesalamine Product and Service
-
Table Teva (Foundation Year, Company Profile and etc.)
-
Table Teva Mesalamine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Teva Mesalamine Product and Service
-
Table AstraZeneca (Foundation Year, Company Profile and etc.)
-
Table AstraZeneca Mesalamine Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca Mesalamine Product and Service
-
Table Takeda (Foundation Year, Company Profile and etc.)
-
Table Takeda Mesalamine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Takeda Mesalamine Product and Service
-
Table Tillotts Pharma (Foundation Year, Company Profile and etc.)
-
Table Tillotts Pharma Mesalamine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Tillotts Pharma Mesalamine Product and Service
-
Table Sandoz Mesalamine (Foundation Year, Company Profile and etc.)
-
Table Sandoz Mesalamine Mesalamine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sandoz Mesalamine Mesalamine Product and Service
-
Table Abbvie (Foundation Year, Company Profile and etc.)
-
Table Abbvie Mesalamine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Abbvie Mesalamine Product and Service
-
Table Nogra Pharma (Foundation Year, Company Profile and etc.)
-
Table Nogra Pharma Mesalamine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Nogra Pharma Mesalamine Product and Service
-
Table Dr Falk Pharma (Foundation Year, Company Profile and etc.)
-
Table Dr Falk Pharma Mesalamine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Dr Falk Pharma Mesalamine Product and Service
-
Table Shanghai Sine Promod Pharmaceutical (Foundation Year, Company Profile and etc.)
-
Table Shanghai Sine Promod Pharmaceutical Mesalamine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Shanghai Sine Promod Pharmaceutical Mesalamine Product and Service
-
Table Mylan (Foundation Year, Company Profile and etc.)
-
Table Mylan Mesalamine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Mylan Mesalamine Product and Service
-
Table Synmosa Biopharma Corporation (Foundation Year, Company Profile and etc.)
-
Table Synmosa Biopharma Corporation Mesalamine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Synmosa Biopharma Corporation Mesalamine Product and Service
-
Table Ferring (Foundation Year, Company Profile and etc.)
-
Table Ferring Mesalamine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Ferring Mesalamine Product and Service
-
Table Allergan (Foundation Year, Company Profile and etc.)
-
Table Allergan Mesalamine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Allergan Mesalamine Product and Service
-
Table Janssen (Johnson & Johnson) (Foundation Year, Company Profile and etc.)
-
Table Janssen (Johnson & Johnson) Mesalamine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Janssen (Johnson & Johnson) Mesalamine Product and Service
-
Table Boehringer Ingelheim (Foundation Year, Company Profile and etc.)
-
Table Boehringer Ingelheim Mesalamine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Boehringer Ingelheim Mesalamine Product and Service
-
